01A genre of phrase, not a set of facts
Cosmetic packaging carries a family of phrases that share a structure: they sound like the output of a process, they use clinical vocabulary, and they do not specify what was done. Dermatologically tested, hypoallergenic, non comedogenic, clinically proven, dermatologist approved, allergy tested.
None of these is a lie. Each usually corresponds to something real that happened. The problem is that the phrase communicates certainty while withholding every detail that would let you judge it, and the buyer supplies the missing confidence themselves.
02Dermatologically tested
The phrase means a dermatologist was involved in testing. Typically that is a tolerance study on a panel of volunteers, assessing whether the product produced irritation under defined conditions. That is a real and useful piece of work.
What the phrase does not say is how many people, for how long, on what skin types, under what conditions, using what endpoints and with what results. A product could be described this way whether nobody reacted or several people did, because the phrase reports that testing occurred rather than what it found.
03Hypoallergenic
Hypoallergenic has no agreed definition in UK cosmetic law and no standard test behind it. In practice it indicates that a formulator has avoided ingredients known to be more frequent sensitisers, most obviously fragrance allergens.
That is a reasonable formulation choice and worth something to people with reactive skin. It is not a guarantee, and it cannot be, because allergy is individual. A person allergic to a specific preservative will react to a hypoallergenic product containing it. The only reliable tool for an individual is knowing what they react to, which usually means patch testing through a dermatology service.
04Non comedogenic
The claim means the product should not block pores and cause comedones. The difficulty is testing. Historical assessment methods relied on animal models whose correlation with human outcomes was questioned, and there is no single agreed human test protocol.
Practically, comedogenicity depends on the whole formula rather than on individual ingredients, on how much is applied, on skin type and on what else is in the routine. A product can carry the claim and still break someone out, and a product without the claim can be perfectly fine on acne prone skin. Where acne is persistent, the useful step is treatment rather than product selection, as covered in the retinoid article.
05Clinically proven
This is the phrase with the widest range of possible meanings. At one end it can describe substantial research. At the other it can describe a study of a few dozen participants over four weeks, funded by the manufacturer, measuring an instrumental endpoint such as a hydration reading rather than anything a user would notice.
UK rules require cosmetic claims to be supported by adequate evidence, and that evidence must be held and available to enforcement authorities. It is not published. The consequence is that clinically proven tells you a file exists, not what is in it. Our general approach to weighing evidence is set out in the assessment criteria.
06The quantified claims that quantify nothing
A related family uses numbers to create precision without content. Up to a stated percentage improvement. Ninety per cent of users agreed. Reduces the appearance of something.
Up to sets a ceiling, not a typical result. Consumer agreement panels measure opinion, not effect, and are frequently run on small self selected groups. Reduces the appearance of is a carefully constructed phrase that describes a visual outcome rather than a physiological one, which is appropriate for a cosmetic and is often read as more than that.
07The line cosmetics cannot cross
There is a genuine and important regulatory boundary here. A product that claims to treat or prevent disease, or to restore, correct or modify physiological functions, may be a medicine rather than a cosmetic, and medicines require authorisation from the MHRA.
This is why cosmetic claims are worded so carefully: reduces the appearance of, helps to, supports. The wording is not evasive by accident, it is the boundary being respected. When a product does cross the line, as with treatments for hair loss or acne, it becomes a medicine with a different regulatory route, which is covered in what is evidenced and what is sold.
08What happens when a claim is challenged
The Advertising Standards Authority investigates complaints about advertising claims, including on packaging where it forms part of a marketing communication, and publishes its rulings. Trading standards and the Office for Product Safety and Standards handle product compliance. Both mechanisms work on specific claims with specific evidence.
That is the practical reason the reassurance vocabulary persists. A vague phrase is harder to challenge than a specific one, and a manufacturer choosing between saying something testable and something evocative faces an obvious incentive.
09Reading a pack, quickly
- Separate testable claims from evocative ones. An SPF figure is testable. Dermatologist approved is not.
- Treat a phrase reporting that testing occurred as neutral. It reports a process, not a result.
- Discount agreement panels entirely. They measure opinion.
- Note the word appearance. Its presence marks a cosmetic claim about how something looks.
- Check the ingredients list against the front. It resolves more questions than any phrase on the pack.